我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

RIP3-CaMKII通路激活程序性坏死在糖尿病心肌缺血/再灌注损伤中的作用

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2018年第2期
页码:
125-129
栏目:
基础研究
出版日期:
2018-02-15

文章信息/Info

Title:
RIP3-CaMKII pathway is involved in activating necroptosis in diabetic myocardial ischemia/reperfusion injury
作者:
薛 涵1李 晨2杨 铮2石曌玲1刘曼玲2殷 玥12马 恒12
(第四军医大学基础部:1.生理学教研室,2.病理生理学教研室,陕西 西安 710032)
Author(s):
XUE Han1 LI Chen2 YANG Zheng2 SHI Zhao-ling1 LIU Man-ling2 YIN Yue12 MA Heng12
(1.Department of Physiology, 2.Department of Pathophysiology, Fourth Military Medical University, Xi’an 710032, Shaanxi, China)
关键词:
糖尿病心肌缺血/再灌注程序性坏死RIP3CaMKII
Keywords:
diabetes myocardial ischemia reperfusion necroptosis RIP3 CaMKII
分类号:
R331.3
DOI:
-
文献标识码:
A
摘要:
目的 本研究旨在探讨受体相互作用蛋白(RIP)3-钙离子/钙调蛋白依赖蛋白激酶(CaMK)II通路激活的程序性坏死(necroptosis)在糖尿病心肌缺血/再灌注(I/R)损伤中的作用。方法 成年(3~4月龄)雄性C57BL/6小鼠70只,随机分为正常组(n=30)与STZ诱导的糖尿病组(n=40)。随后采用小鼠急性心肌I/R在体模型(缺血30 min再灌注4 h)。再灌注后取心肌组织,一部分应用Western blot法检测RIP3-CaMKII信号的表达及修饰变化,另一部分做冰冻切片组织免疫荧光,通过伊文氏蓝阳性区域的面积占比反映程序性坏死的程度。结果 与正常组相比,糖尿病组小鼠I/R后心肌程序性坏死程度显著升高(P<0.05);在糖尿病I/R心肌中RIP3表达水平和磷酸化CaMKII水平较正常组I/R心肌均显著升高(P<0.05)。对糖尿病小鼠再灌注前给予CaMKII抑制剂KN-93处理可以显著降低糖尿病心肌I/R后的程序性坏死比例(P<0.05)。结论 本研究证实在糖尿病心肌I/R损伤中程序性坏死显著增加,提示RIP3-CaMKII信号增强引发心肌程序性坏死在糖尿病心肌缺血易损中起重要作用。
Abstract:
AIM To investigate the role of necroptosis activated by RIP3-CaMKII pathway under conditions of diabetic myocardial ischemia/reperfusion. METHODS Male C57BL/6 mice (aged 3-4 months) were randomized into diabetes and normal control groups. For the diabetes group, a model of type 1 diabetes mellitus was employed. Mice were subjected to a myocardial I/R model utilizing anterior descending artery ligation for 30 minutes followed by 4-hour reperfusion. Myocardial tissue was excised after reperfusion. Western blot was used to detect RIP3 and phospho-CaMKII expression and cryosection and immunofluorescence were used to evaluate necroptosis by Evans-blue dye positive area percentage. RESULTS Compared with the normal I/R group, the diabetic I/R group showed enhanced necroptosis indicated by a higher EBD-positive area percentage (P<0.05) and increased expression of RIP3 and phospho-CaMKII (P<0.05). KN-93, an inhibitor of CaMKII, significantly reduced necroptosis in the diabetic I/R group (P<0.05). CONCLUSION Necroptosis is enhanced in diabetic myocardial I/R injury, implying that enhanced the RIP3-CaMKII pathway, which activates myocardial necroptosis, plays an important role in diabetic myocardial I/R.

参考文献/References

[1]Shah MS,Brownlee M.Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes[J].Circ Res,2016,118(11):1808-1829.

[2]Donahoe SM,Stewart GC,McCabe CH,et al.Diabetes and mortality following acute coronary syndromes[J].JAMA,2007,298(7):765-775.

[3]Kung G,Konstantinidis K,Kitsis RN.Programmed necrosis,not apoptosis, in the heart[J].Circ Res,2011,108(8):1017-1036.

[4]Zhang T,Zhang Y,Cui M,et al.CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis[J].Nat Med,2016,22(2):175-182.

[5]Burchfield JS,Xie M,Hill JA.Pathological ventricular remodeling:mechanisms:part 1 of 2[J].Circulation,2013,128(4): 388-400.

[6]Luo M,Guan X,Luczak ED,et al.Diabetes increases mortality after myocardial infarction by oxidizing CaMKII[J].J Clin Invest,2013,123(3):1262-1274.

[7]Sun L,Wang H,Wang Z,et al.Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase[J].Cell,2012,148(1-2):213-227.

[8]Nakagawa T,Shimizu S,Watanabe T,et al.Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death[J].Nature,2005,434(7033):652-658.

[9]Cho YS,Challa S,Moquin D,et al.Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation[J].Cell,2009,137(6):1112-2113.

[10]Moriwaki K,Chan FK.RIP3:a molecular switch for necrosis and inflammation[J].Genes Dev,2013,27(15):1640-1649.

[11]Vila-Petroff M,Salas MA,Said M,et al.CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury[J].Cardiovasc Res,2007,73(4):689-698.

[12]Erickson JR, Pereira L, Wang L, et al. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation[J].Nature,2013,502(7471):372-376.

[13]Larocca TJ,Sosunov SA,Shakerly NL,et al.Hyperglycemic Conditions Prime Cells for RIP1-dependent Necroptosis[J].Journal of Biological Chemistry,2016,291(26):13753-13761.

备注/Memo

备注/Memo:
收稿日期:2017-10-16.基金项目:国家自然科学基金项目资助(81322004,31671424);陕西省社发攻关项目资助(2011KJXX66,2015KW-050) 通讯作者:马恒,副教授,主要从事心肌内源性保护机制研究 Email:hengma@fmmu.edu.cn 作者简介:薛涵,硕士生 Email:362703437@qq.com
更新日期/Last Update: 1900-01-01